Ahmad H Ibrahim1, Haibo Li2, Sawsan S Al-Rawi3, Aman Shah Abdul Majid4, Omar Am Al-Habib1, Xiaobo Xia2, Amin Ms Abdul Majid3, Dan Ji2,5. 1. Depatment of Biology, Faculty of Sciences, University of ZakhoKurdistan Region, Iraq. 2. Department of Ophthalmology, Xiangya Hospital, Central South UniversityChangsha 410000, Hunan Province, China. 3. John Curtin School of Medical Research, College of Medicine, Australian National UniversityAustralian. 4. Department of Pharmacology, Quest International UniversityPerak, Malaysia. 5. The First People's Hospital of ChangdeChangde 415000, Hunan Province, China.
Abstract
OBJECTIVE: The process of wound healing involves activation of keratinocytes, fibroblasts, endothelial cells, etc. Angiogenesis is crucial during the process of wound healing. Virgin coconut oil is widely utilized in South Asia for various purposes including food, medicinal and industrial applications. This study aimed to evaluate the potency of fermented virgin coconut oil (FVCO) in angiogenesis and wound healing via both in vitro and in vivo assays. METHODS: Human umbilical vein endothelial (HUVEC), fibroblast (CCD-18) and retinal ganglion (RGC-5) cells were cultured in medium containing different concentrations of FVCO. The proliferation, migration and morphological changes of cells were determined. The angiogenic effect of FVCO was evaluated by rat aortic assay. The therapeutic effect of FVCO on wound healing was further assessed in a wound excision model in Sprague Dawley rats. The expression of phospho-VEGFR2 (vascular endothelial growth factor receptor 2) in HUVECs was detected by Western blot. RESULTS: FVCO (6 and 12 µg/mL) significantly improved the proliferation of HUVEC, CCD-18 and RGC-5 cells (P < 0.05 or 0.01). FVCO (25 µg/mL) markedly increased the migration ability of CCD-18 and RGC-5 cells (P < 0.05). FVCO did not affect cell morphology as indicated by fluorescein diacetate (FDA), rhodamine 123 and Hoechst staining. FVCO (25, 50 and 100 µg/mL) significantly stimulated the ex vivo blood vessel formation as compared with negative control (P < 0.05). Rats in FVCO group had significantly smaller wound size, higher wound healing percentage, and shorter wound closure time when compared with control group since day 8 (P < 0.05), suggesting that oral FVCO administration notably promoted the wound healing process. FVCO treatment (6 and 12 µg/mL) significantly enhanced the phospho-VEGFR2 expression in HUVECs (P = 0.006 and 0.000, respectively). CONCLUSION: Our study confirms a high angiogenic and wound healing potency of FVCO that might be mediated by the regulation of VEGF signing pathway.
OBJECTIVE: The process of wound healing involves activation of keratinocytes, fibroblasts, endothelial cells, etc. Angiogenesis is crucial during the process of wound healing. Virgin coconut oil is widely utilized in South Asia for various purposes including food, medicinal and industrial applications. This study aimed to evaluate the potency of fermented virgin coconut oil (FVCO) in angiogenesis and wound healing via both in vitro and in vivo assays. METHODS:Human umbilical vein endothelial (HUVEC), fibroblast (CCD-18) and retinal ganglion (RGC-5) cells were cultured in medium containing different concentrations of FVCO. The proliferation, migration and morphological changes of cells were determined. The angiogenic effect of FVCO was evaluated by rat aortic assay. The therapeutic effect of FVCO on wound healing was further assessed in a wound excision model in Sprague Dawley rats. The expression of phospho-VEGFR2 (vascular endothelial growth factor receptor 2) in HUVECs was detected by Western blot. RESULTS:FVCO (6 and 12 µg/mL) significantly improved the proliferation of HUVEC, CCD-18 and RGC-5 cells (P < 0.05 or 0.01). FVCO (25 µg/mL) markedly increased the migration ability of CCD-18 and RGC-5 cells (P < 0.05). FVCO did not affect cell morphology as indicated by fluorescein diacetate (FDA), rhodamine 123 and Hoechst staining. FVCO (25, 50 and 100 µg/mL) significantly stimulated the ex vivo blood vessel formation as compared with negative control (P < 0.05). Rats in FVCO group had significantly smaller wound size, higher wound healing percentage, and shorter wound closure time when compared with control group since day 8 (P < 0.05), suggesting that oral FVCO administration notably promoted the wound healing process. FVCO treatment (6 and 12 µg/mL) significantly enhanced the phospho-VEGFR2 expression in HUVECs (P = 0.006 and 0.000, respectively). CONCLUSION: Our study confirms a high angiogenic and wound healing potency of FVCO that might be mediated by the regulation of VEGF signing pathway.
Authors: Naiane F B Alves; Suênia K P Porpino; Matheus M O Monteiro; Enéas R M Gomes; Valdir A Braga Journal: Appl Physiol Nutr Metab Date: 2015-02-09 Impact factor: 2.665
Authors: Ahmad H Ibrahim; Md Shamsuddin Sultan Khan; Sawsan S Al-Rawi; Mohamed B Khadeer Ahamed; Aman Shah Bin Abdul Majid; Fouad Saleih R Al-Suede; Dan Ji; Amin Malik Shah Abdul Majid Journal: Regul Toxicol Pharmacol Date: 2016-10-15 Impact factor: 3.271
Authors: Hua Teng; Zheng Gang Zhang; Lei Wang; Rui Lan Zhang; Li Zhang; Dan Morris; Sara R Gregg; Zhenhua Wu; Angela Jiang; Mei Lu; Berislav V Zlokovic; Michael Chopp Journal: J Cereb Blood Flow Metab Date: 2007-10-31 Impact factor: 6.200